Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

4 Stocks To Watch: CALA, MXL, PAYC, ZIOP

Published 11/05/2015, 12:09 AM
Updated 07/09/2023, 06:31 AM

It was a sloppy day on Wall Street on Wednesday, and the indices were lower, but a lot of our stocks did well. Let’s take a look at them.

Calithera Biosciences, Inc. (O:CALA), one of our current swing trades, is doing well. It had a declining topsline, formed a base, broke out, consolidated, held the moving averages, created a new trendline, and on Wednesday, it popped 93 cents to 9.73, or 11%, on 550,000 shares traded. It’s near the resistance level at Wednesday’s high around the 9.80 area. If there’s a spike high at 10.59 may be tested short-term, maybe even taken out. Mid-channel targets are around 11 1/2-3/4-12, 14, and potentially 17.

MaxLinear, Inc. (N:MXL) had a wonderful session on Wednesday, exploding 3.66 to 16.79, or 28%, on 6.7 million shares on a strong earnings report. That move takes out a lot of resistance and the top of the channel. The all-time high is near the IPO high at 19 1/2. The target is 18-19 1/2 going forward. This is resistance in this zone, so it could get a pullback as well.

Paycom Software, Inc. (N:PAYC) has been phenomenal all year, going from 12, and change, to the mid 40s. The significance of the breakaway gap on Wednesday is that it jumped 6.58 to 45.73, or 17%, on 4.5 million shares. That’s big. Mid-channel target is about 49-50. Longer-term target is in the mid 60s.

Silver Spring Networks, Inc. (N:SSNI) finally broke out in a falling wedge on Wednesday, up 1.78 to 14.87, or 13.6%, on 1.8 million shares. It got up to resistance and closed near it. The next target would have to be 18-18 1/2, and then 20 1/2-21.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Other stocks on the long side include BroadSoft, Inc. (O:BSFT), Diplomat Pharmacy, Inc. (N:DPLO), Energy Focus, Inc. (O:EFOI), Genetic Technologies Limited (O:GENE), Globant (N:GLOB), MaxLinear, Inc. (N:MXL), Myriad Genetics, Inc. (O:MYGN), NantKwest, Inc. (O:NK), Solar3D, Inc. (O:SLTD), Trevena, Inc. (O:TRVN), and ZIOPHARM Oncology, Inc. (O:ZIOP).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.